BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 14732883)

  • 21. Long-term survivor of brain metastases from malignant melanoma.
    Mahmood H; Faheem M; Asghar AH; Irfan J
    J Coll Physicians Surg Pak; 2010 Dec; 20(12):832-4. PubMed ID: 21205554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of gamma knife surgery in the management of cerebral metastases from melanoma.
    Christopoulou A; Retsas S; Kingsley D; Paddick I; Lindquist C
    Melanoma Res; 2006 Feb; 16(1):51-7. PubMed ID: 16432456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of brain metastases in uncommon tumors.
    Tosoni A; Lumachi F; Brandes AA
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):783-93. PubMed ID: 15485313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in therapy for melanoma brain metastases.
    Flanigan JC; Jilaveanu LB; Chiang VL; Kluger HM
    Clin Dermatol; 2013; 31(3):264-81. PubMed ID: 23608446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
    Vestermark LW; Larsen S; Lindeløv B; Bastholt L
    Acta Oncol; 2008; 47(8):1526-30. PubMed ID: 18607876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of melanoma brain metastases: a new paradigm.
    Carlino MS; Fogarty GB; Long GV
    Cancer J; 2012; 18(2):208-12. PubMed ID: 22453023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
    Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
    Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
    Eigentler TK; Figl A; Krex D; Mohr P; Mauch C; Rass K; Bostroem A; Heese O; Koelbl O; Garbe C; Schadendorf D;
    Cancer; 2011 Apr; 117(8):1697-703. PubMed ID: 21472716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy.
    Gaudy-Marqueste C; Regis JM; Muracciole X; Laurans R; Richard MA; Bonerandi JJ; Grob JJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):809-16. PubMed ID: 16682138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Brain and gallbladder metastases 10 years after local excision of a cutaneous malignant melanoma].
    Gawenda M; Franzen D; Lorenzen J; Müller U
    Dtsch Med Wochenschr; 1995 Mar; 120(9):289-92. PubMed ID: 7875079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma-induced brain metastases.
    McWilliams RR; Rao RD; Buckner JC; Link MJ; Markovic S; Brown PD
    Expert Rev Anticancer Ther; 2008 May; 8(5):743-55. PubMed ID: 18471047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant melanoma metastatic to the ovary.
    Piura B; Kedar I; Ariad S; Meirovitz M; Yanai-Inbar I
    Gynecol Oncol; 1998 Feb; 68(2):201-5. PubMed ID: 9514807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rational surgical approach to the treatment of distant melanoma metastases.
    Martinez SR; Young SE
    Cancer Treat Rev; 2008 Nov; 34(7):614-20. PubMed ID: 18556133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survivors after gamma knife radiosurgery for brain metastases.
    Kondziolka D; Martin JJ; Flickinger JC; Friedland DM; Brufsky AM; Baar J; Agarwala S; Kirkwood JM; Lunsford LD
    Cancer; 2005 Dec; 104(12):2784-91. PubMed ID: 16288488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanoma.
    Nieder C; Adam M; Astner ST
    Anticancer Res; 2008; 28(2B):1325-7. PubMed ID: 18505073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
    Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
    Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidisciplinary management of brain metastases.
    Eichler AF; Loeffler JS
    Oncologist; 2007 Jul; 12(7):884-98. PubMed ID: 17673619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for survival in melanoma patients with brain metastases.
    Davies MA; Liu P; McIntyre S; Kim KB; Papadopoulos N; Hwu WJ; Hwu P; Bedikian A
    Cancer; 2011 Apr; 117(8):1687-96. PubMed ID: 20960525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.